← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Aplos Medical Inc
Eden Prairie, MN
$3,872,315
Total funding
4
Grants
Funding over time
peak $795.7K · FY2013–25$1M$750K$500K$250K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,872,315 · 4
By mechanism
R44$3,110,549 · 2
SB1$570,706 · 1
R43$191,060 · 1
Investigators at Aplos Medical Inc
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
A Simple and Implantable Device for the Treatment of Gastroesophageal Reflux Disease$795,705
R44 · FY2016 · DK
A Simple and Implantable Device for the Treatment of Gastroesophageal Reflux Disease$704,295
R44 · FY2015 · DK
Clinical Feasibility Study of a Novel Flexible, Non-occlusive GERD Treatment Device$596,460
R44 · FY2021 · DK
Readying the commercialization of Omega device as an improved safe and efficacious treatment for drug-failed GERD patients$570,706
SB1 · FY2025 · DK
Clinical Feasibility Study of a Novel Flexible, Non-occlusive GERD Treatment Device$562,772
R44 · FY2022 · DK
Clinical Feasibility Study of a Novel Flexible, Non-occlusive GERD Treatment Device$451,317
R44 · FY2024 · DK
Simple & Safe Implantable Device for Treatment of Gastroesophageal Reflux Disease$191,060
R43 · FY2013 · DK